NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Private Equity Firms Stockpile Dry Powder Ahead of Market Downturn

$1.2 trillion in dry powder, a reserve of unspent capital, is currently held by private equity firms globally. This significant war chest has been accumulated in anticipation of a potential market downturn, allowing these firms to capitalize on undervalued assets.

The buildup of dry powder is a strategic move by private equity firms to be prepared for an uncertain market environment. Kohlberg Kravis Roberts (KKR), a leading private equity firm, has $225 billion in dry powder, one of the largest reserves in the industry. Blackstone Group, another prominent private equity firm, has $195 billion in its dry powder, positioning itself for future opportunities.

Private equity firms' readiness for a market downturn is also reflected in their investment strategies. Bain Capital, a global private equity firm, has been actively investing in sectors such as healthcare and technology, where it sees potential for growth despite market volatility. The firm's commitment to these sectors demonstrates its confidence in their resilience and long-term prospects.

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

The accumulation of dry powder by private equity firms serves as a testament to their ability to adapt to changing market conditions and capitalize on opportunities. As the market continues to evolve, these firms will be well-positioned to deploy their dry powder and drive growth in the private equity industry.

Investor Takeaway

Investors should be prepared for a potential market rebound.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.